Wellesley Pharmaceuticals utilizes world class consultants and partners as needed to work quickly and efficiently towards our goals.
CEO and President, Wellesley Pharmaceuticals, LLC
Chief Scientist and Professor, Gene Expression and Regulation, The Wistar Institute
Business Development Consultant, CEO, Health System Reform SAL
Patent Lawyer, Andrews Kurth Kenyon, Partner
PLEASE NOTE THAT NOCTUROL HAS NOT BEEN APPROVED BY THE FDA OR EMA OR ANY OTHER REGULATORY AUTHORITY. NOCTUROL IS CURRENTLY UNDERGOING A PHASE 2 CLINICAL TRIAL.